Back to search

Ireland· IE-PA-PA0896/019/001

Maxitrol 0.1% w/v, 6000 IU/ml, 3500 IU/ml eye drops, suspension

A dexamethason mit antiinfektiva product containing dexamethasone + polymyxin b sulfate + neomycin sulfate, registered in Ireland by Novartis Ireland Limited. The same ATC class is registered in 11 of our 19 countries.

ATC S01CA01

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedMaxitrol 0.1% w/v, 6000 IU/ml, 3500 I…ATCS01CA01REGISTER NO.IE-PA-PA0896/019/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Dexamethason mit antiinfektiva is registered in 11 of 19 countries.

Countries holding a registration under ATC S01CA01 (dexamethason mit antiinfektiva), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose

Dexamethason mit antiinfektiva · ATC S01CA01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Dexamethasone + Polymyxin b sulfate + Neomycin sulfate
Manufacturer
Novartis Ireland Limited
Country
Ireland (IE)
ATC code
S01CA01
ATC class
Dexamethason mit Antiinfektiva
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA0896/019/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dexamethason mit antiinfektiva in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dexamethason mit antiinfektiva products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Belgium · Maxitrol
  • Bulgaria · Макситрол, Неладекс
  • Cyprus · Isopto Maxitrol
  • Czechia · Maxitrol
  • Germany · Isopto-Max
  • Estonia · Maxitrol
  • Spain · Maxitrol
  • France · Maxidrol
  • United Kingdom (Northern Ireland) · Maxitrol
  • Croatia · Maxitrol
  • Iceland · Maxitrol
  • Lithuania · Maxitrol
  • Luxembourg · Maxitrol
  • Latvia · Maxitrol
  • Norway · Maxitrol
  • Poland · Maxitrol
  • Romania · Maxitrol
  • Slovenia · Maxitrol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4596c4d8-a5ee-47ea-9c87-2d4c01678b08
GET /v1/drugs/4596c4d8-a5ee-47ea-9c87-2d4c01678b08?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Eye drops, suspension",
  "routes": [
    "Ocular use"
  ],
  "source": "hpra",
  "atc_all": [
    "S01CA",
    "S01CA01"
  ],
  "strength": null,
  "pa_number": "PA0896/019/001",
  "substances": [
    "Dexamethasone",
    "Polymyxin b sulfate",
    "Neomycin sulfate"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Not marketed",
  "authorised_at": "01/04/1988",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about dexamethason mit antiinfektiva.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.